Home 
Today's Top Picks 
Top Performers 
Watchlist 
My Robo Portfolios 
ETF Zone 
Help & Tutorial - Chart
- Upturn Summary
- Highlights
- Revenue
- Valuation
Upturn AI SWOT - About
AHCO 
Adapthealth Corp (AHCO)
- BUY Advisory
- SELL Advisory (Profit)
- SELL Advisory (Loss)
- Profit
- Loss
- Pass (Skip investing)
Stock price based on last close (see disclosures)
- ALL
- 1Y
- 1M
- 1W
Upturn Advisory Summary
11/17/2025: AHCO (1-star) has a low Upturn Star Rating. Not recommended to BUY.
Upturn Star Rating
Not Recommended Performance
These Stocks/ETFs, based on Upturn Advisory, consistently fall short of market performance, signaling caution before investing.
Number of Analysts
8 Analysts rated it
Limited analyst coverage, niche firm, research info may be scarce.
1 Year Target Price $13.25
1 Year Target Price $13.25
| 5 | Strong Buy |
| 1 | Buy |
| 2 | Hold |
| 0 | Sell |
| 0 | Strong Sell |
Analysis of Past Performance
Type Stock | Historic Profit -75.63% | Avg. Invested days 21 | Today’s Advisory WEAK BUY |
Upturn Star Rating | Upturn Advisory Performance  1.0 | Stock Returns Performance  1.0 |
| Profits based on simulation | Last Close 11/17/2025 |
Key Highlights
Company Size Small-Cap Stock | Market Capitalization 1.26B USD | Price to earnings Ratio 16.71 | 1Y Target Price 13.25 |
Price to earnings Ratio 16.71 | 1Y Target Price 13.25 | ||
Volume (30-day avg) 8 | Beta 1.78 | 52 Weeks Range 7.11 - 11.63 | Updated Date 11/17/2025 |
52 Weeks Range 7.11 - 11.63 | Updated Date 11/17/2025 | ||
Dividends yield (FY) - | Basic EPS (TTM) 0.55 |
Analyzing Revenue: Products, Geography and Growth
Revenue by Products
Product revenue - Year on Year
Earnings Date
Report Date 2025-11-11 | When - | Estimate 0.24 | Actual 0.2334 |
Profitability
Profit Margin 2.53% | Operating Margin (TTM) 8.18% |
Management Effectiveness
Return on Assets (TTM) 3.64% | Return on Equity (TTM) 5.52% |
Valuation
Trailing PE 16.71 | Forward PE 9.01 | Enterprise Value 3068132629 | Price to Sales(TTM) 0.39 |
Enterprise Value 3068132629 | Price to Sales(TTM) 0.39 | ||
Enterprise Value to Revenue 0.94 | Enterprise Value to EBITDA 4.8 | Shares Outstanding 135424334 | Shares Floating 89572040 |
Shares Outstanding 135424334 | Shares Floating 89572040 | ||
Percent Insiders 8.13 | Percent Institutions 104.06 |
Upturn AI SWOT
Adapthealth Corp
Company Overview
History and Background
Adapthealth Corp. was founded in 2012 and has grown through acquisitions to become a leading provider of home medical equipment (HME) and related services.
Core Business Areas
- Sleep Therapy Equipment: Provides CPAP and BiPAP machines, masks, and related supplies for the treatment of sleep apnea.
- Mobility Equipment: Offers wheelchairs, scooters, and other mobility devices to assist individuals with mobility limitations.
- Oxygen Therapy: Supplies oxygen concentrators, tanks, and related respiratory equipment.
- Other DME and Supplies: Provides other durable medical equipment and supplies such as orthotics, incontinence products, and wound care products.
Leadership and Structure
Luke McGee is the Chief Executive Officer. The company has a typical corporate structure with departments for finance, operations, sales, and marketing. The Board of Directors oversees strategic direction.
Top Products and Market Share
Key Offerings
- CPAP/BiPAP Therapy: Provides equipment and supplies for sleep apnea treatment. Adapthealth claims a significant share in the fragmented home sleep therapy market. Competitors include ResMed (RMD), Philips Respironics (owned by Philips (PHG)), and Lincare Holdings.
- Competitors: ResMed (RMD), Philips Respironics (owned by Philips (PHG)), and Lincare Holdings.
- Competitors: Numotion, National Seating & Mobility, and local DME providers.
- Mobility Solutions: Offers a range of mobility equipment like wheelchairs and scooters. Market share is less defined within this segment, with competition from local and regional providers. Competitors include Numotion, National Seating & Mobility, and local DME providers.
Market Dynamics
Industry Overview
The home medical equipment market is driven by an aging population, increasing prevalence of chronic diseases, and a shift towards home-based healthcare. The industry is fragmented and subject to regulatory changes and reimbursement pressures.
Positioning
Adapthealth Corp. is positioned as a leading provider of HME, focusing on scale, operational efficiency, and acquisitions to gain market share. Their competitive advantages lie in their broad product offerings, extensive distribution network, and established relationships with healthcare providers.
Total Addressable Market (TAM)
The global durable medical equipment market is estimated to reach hundreds of billions of dollars. Adapthealth is positioned to capture a significant portion of this TAM through organic growth and acquisitions.
Upturn SWOT Analysis
Strengths
- Strong market position in the HME industry
- Extensive distribution network
- Proven track record of acquisitions
- Recurring revenue stream from supplies
Weaknesses
- High debt levels due to acquisitions
- Dependence on reimbursement rates from payers
- Integration risks associated with acquisitions
- Geographic concentration in certain regions
Opportunities
- Further acquisitions to expand market share
- Growth in the home healthcare market
- Expansion into new product categories
- Technological advancements in HME
Threats
- Changes in reimbursement policies
- Increased competition from other HME providers
- Economic downturn affecting healthcare spending
- Product recalls or safety concerns
Competitors and Market Share
Key Competitors
- RMD
- PHG
- LHCG
Competitive Landscape
Adapthealth competes on scale, product breadth, and service quality. Competitors may have advantages in specific product areas or geographic regions.
Major Acquisitions
MedEquip Alert
- Year: 2020
- Acquisition Price (USD millions): 30
- Strategic Rationale: Expanded capabilities in remote patient monitoring.
Growth Trajectory and Initiatives
Historical Growth: Adapthealth has grown significantly through acquisitions and organic growth in recent years.
Future Projections: Analyst estimates would suggest future growth is dependent on continued acquisitions and the expansion of existing product lines.
Recent Initiatives: Recent initiatives may include acquisitions, new product launches, and expansion into new markets.
Summary
Adapthealth is a leading HME provider with a solid market position. Its aggressive acquisition strategy has fueled growth but also increased debt. Success depends on integrating acquisitions, managing reimbursement risks, and capitalizing on the growing home healthcare market.
Similar Stocks
Sources and Disclaimers
Data Sources:
- Company filings
- Industry reports
- Analyst estimates
- Third-party market research
Disclaimers:
The information provided is for informational purposes only and should not be construed as investment advice. Market share data is approximate and based on available information. Financial data is subject to change.
AI Summarization is directionally correct and might not be accurate.
Summarized information shown could be a few years old and not current.
Fundamental Rating based on AI could be based on old data.
AI-generated summaries may have inaccuracies (hallucinations). Please verify the information before taking action.
About Adapthealth Corp
Exchange NASDAQ | Headquaters Plymouth Meeting, PA, United States | ||
IPO Launch date 2018-05-24 | CEO & Director Ms. Suzanne M. Foster M.P.H. | ||
Sector Healthcare | Industry Medical Devices | Full time employees 10500 | Website https://adapthealth.com |
Full time employees 10500 | Website https://adapthealth.com | ||
AdaptHealth Corp., together with its subsidiaries, distributes home medical equipment (HME), medical supplies, and home and related services in the United States. The company offers sleep therapy equipment, supplies, and related services, such as CPAP and bi-PAP services to individuals suffering from obstructive sleep apnea; medical devices and supplies, including continuous glucose monitors and insulin pumps for the treatment of diabetes; HME to patients discharged from acute care and other facilities; oxygen and related chronic therapy services in the home; and other HME devices and supplies on behalf of chronically ill patients with wound care, urological, incontinence, ostomy, and nutritional supply needs. It also provides wheelchairs, hospital beds, oxygen concentrators, insulin pumps, CPAP masks and related supplies, diabetes management and wound care supplies, wheelchair cushion accessories, orthopedic bracing, breast pumps and supplies, walkers, commodes and canes, and nutritional and incontinence supplies. The company services beneficiaries of Medicare, Medicaid, and commercial insurance payors. AdaptHealth Corp. was founded in 2012 and is headquartered in Plymouth Meeting, Pennsylvania.
Note: This website is maintained by Upturn Corporation, which is an investment adviser registered with the U.S. Securities and Exchange Commission. Such registration does not imply a certain level of skill or training. Investing in securities has risks. Past performance is no guarantee of future returns. No assurance is provided as to any particular investment return, and you may lose money using our services. You are strongly advised to consult appropriate counsel before making any investments in companies you learn about through our services. You should obtain appropriate legal, tax, investment, accounting, and other advice that takes into account your investment portfolio and overall financial situation. You are solely responsible for conducting due diligence on a potential investment. We do not affect trades for you. You will select your own broker through which to transact. Investments are not FDIC insured, they are not guaranteed, and they may lose value. Please see the Privacy Policy, Terms of Use, and Disclosure for more information.